Researchers from the Hebrew University of Jerusalem and the IDF’s Medical Corps have discovered a peptide to activate Protein Kinase C-epsilon (PKC-ε) and significantly improve survival rates of patients (including wounded soldiers) who suffer massive blood loss.
Breakthrough treatment for massive blood loss
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.